NovAccess Global is a biomedical company accelerating novel cancer diagnostics and therapeutics.

Mission:

To discover, develop and bring to market novel and innovative medicine and medical devices to improve the quality of care for cancer and neurological patients.

Growth Strategy:

NovAccess Global, Inc. is building long-term shareholder value through intelligent acquisition of assets in clinical stage research and development, balanced with medical assets in market. We bring together the best technological assets and the best scientific and executive team to accelerate taking these assets to market. We also promote growth of products in the market and utilize our expert Board of Advisors to increase the market share of our assets. We seek to have rapid growth through acquisition and organic growth. We are focused on cancer technologies that fit into our business plan but are also responsive to uniquely focused opportunities.

Vision:

To accelerate and advance diagnostics and therapeutics in cancer and neurological diseases. NovAccess Global has created a model that will redefine standards of progress in the effective diagnosis and treatment of cancer and neurological diseases, by synergizing breakthrough advancements in blockchain-powered AI platform technologies.

Our Cutting-Edge Approach:

Utilization of blockchain-powered AI to collect and analyze data mined through state-of-the-art bio-sensing technologies will allow game-changing improvements in discovery speed and implementation of cancer and neurological diagnostics and immunotherapeutics.

Novel immunotherapeutic approaches to treat brain tumors and neurological diseases

Novel diagnostic tools for earlier and more accurate detection and staging of cancer

AI-based platform and block chain technologies for a more personalized, patient-centered approach to improving the quality of life for cancer and neurological patients

NovAccess Global is a biomedical company accelerating novel cancer diagnostics and therapeutics.

Mission:

To discover, develop and bring to market novel and innovative medicine and medical devices to improve the quality of care for cancer and neurological patients.

Growth Strategy:

NovAccess Global, Inc. is building long-term shareholder value through intelligent acquisition of assets in clinical stage research and development, balanced with medical assets in market. We bring together the best technological assets and the best scientific and executive team to accelerate taking these assets to market. We also promote growth of products in the market and utilize our expert Board of Advisors to increase the market share of our assets. We seek to have rapid growth through acquisition and organic growth. We are focused on cancer technologies that fit into our business plan but are also responsive to uniquely focused opportunities.

Vision:

To accelerate and advance diagnostics and therapeutics in cancer and neurological diseases. NovAccess Global has created a model that will redefine standards of progress in the effective diagnosis and treatment of cancer and neurological diseases, by synergizing breakthrough advancements in blockchain-powered AI platform technologies.

Our Cutting-Edge Approach:

Utilization of blockchain-powered AI to collect and analyze data mined through state-of-the-art bio-sensing technologies will allow game-changing improvements in discovery speed and implementation of cancer and neurological diagnostics and immunotherapeutics.

Novel immunotherapeutic approaches to treat brain tumors and neurological diseases

Novel diagnostic tools for earlier and more accurate detection and staging of cancer

AI-based platform and block chain technologies for a more personalized, patient-centered approach to improving the quality of life for cancer and neurological patients